Statement by Ralph G. Neas, President and CEO, Generic Pharmaceutical Association, on Senate Vote to Restore FDA Sequestered User Fees

Published Online: Thursday, January 16, 2014
Follow Pharmacy_Times:
PRESS RELEASE

WASHINGTON DC, (January 16, 2014) — Today, the U.S. Senate joined the House of Representatives in voting to restore $85 million in Food and Drug Administration (FDA) sequestered user fees, reflecting bipartisan recognition of the critical need to ensure the agency has the resources required to carry out its mission, including the review and approval of affordable generic medicines and biosimilars.

GPhA would especially like to congratulate Senate Agriculture and FDA Appropriations Subcommittee Chair Mark Pryor and Ranking Member Roy Blunt for their unwavering commitment to restoring industry-supported FDA user fees and ensuring that millions of Americans have timely access to more affordable generic medicines.

View the January 15 press release here.
Related Articles
Today, an expert panel at the 2015 Generic Pharmaceutical Association Annual Meeting, “FDA and Industry Perspectives on Quality Culture,” convened to discuss a shared commitment with industry to the highest standards of manufacturing quality and regulatory processes.
The Generic Pharmaceutical Association today announced the election of its 2015 Executive Committee and Board of Directors.
The Generic Pharmaceutical Association and its members applaud the significant progress made by the agency during Commissioner of Food and Drugs Dr. Margaret Hamburg’s six years leading the U.S. Food and Drug Administration. Throughout her tenure, Dr. Hamburg has been a tireless advocate for patient safety and a leader in efforts to assure that FDA decisions are guided by scientific principles.
“The Generic Pharmaceutical Association (GPhA) is deeply disappointed in today’s 21st Century Cures discussion draft. While we appreciate that it is a draft, in its current form, the bill would upset the important balance between creating competition and encouraging innovation in the pharmaceutical marketplace, putting savings at risk and limiting access to affordable medicines for millions of American patients.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$